Reveal Biosensors
Reveal Biosensors
Website
Profile
Reveal Biosensors has developed the world's first Energy Conversion Monitor. This sensor provides a new, non-invasive measurement of cellular oxygen demand that offers much greater clinical relevance and usefulness than current heart rate and blood oxygen supply information. We have evidence that this new information has the potential of breakthrough advancement in the diagnosis and treatment of several important health challenges, including compromised breathing during sleep, remote patient monitoring, and guidance of oxygen therapy during surgical anesthesia and critical care. Reveal will commercialize this new sensor technology through licensing relationships to the Sports, Fitness/Wellness, Worker Safety, and Healthcare markets.
Filtered by:
Reveal Biosensors
Company
Topic
Show
2019
16 Oct 2019
IDTechEx Announces the Winners of Launchpad
IDTechEx Launchpad will showcase innovations from 12 start-up companies at the IDTechEx Show! held in Santa Clara Convention Center, CA, USA (www.IDTechEx.com/USA). All winners will be showing a new working prototype or product, many for the first time.
22 Aug 2019
Reveal Biosensors
IDTechEx was updated on the latest developments and messaging from Reveal Biosensors on their 'Energy Conversion Monitor', a wearable optical sensor which is highly responsive to physiological stress.
Included are:
2018
21 Nov 2018
Reveal Biosensors
IDTechEx met with Stephen Ursenbach and Guy Hatch, CEO and CTO respectively as well as being co-founders of Reveal Biosensors. They have developed an 'energy conversion monitor' based on a wearable sensor, used in the diagnosis and management of skin tissue hypoxia and linked areas such as sleep disordered breathing (sleep apnea, etc.).
Included are:
